Compare Humana Inc (HUM) vs JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs JPMorgan Nasdaq Equity Premium Income ETF — how do they compare? Humana Inc trades at $442.02 (market cap $47.61B), while JPMorgan Nasdaq Equity Premium Income ETF trades at $61.23 (market cap $44.68B). The key difference: Humana Inc and JPMorgan Nasdaq Equity Premium Income ETF are close in size by market cap, and Humana Inc pays a 0.89% dividend while JPMorgan Nasdaq Equity Premium Income ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and JPMorgan Nasdaq Equity Premium Income ETF for 65 Days on average.
| HUM | JEPQ | |
|---|---|---|
Market Cap | $47.61B | $44.68B |
Volume | 1,827,332 | 6,315,250 |
Sector | Health | Income / Options Overlay |
52-Week High | $409.85 | $61.46 |
52-Week Low | $163.67 | $53.77 |
Typical Hold Time | 53 Days | 65 Days |
Enterprise Value | $54.97B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
JEPQ trades at $61.27 with minimal daily movement (+0.03%), showing technical bullish momentum with strong moving average support. The ETF maintains an estimated 11% annualized yield through its covered call strategy on Nasdaq-100 stocks, though recent oscillators suggest potential near-term consolidation. Recent news highlights JEPQ's popularity among income-focused investors seeking monthly distributions from tech exposure.
JEPQ offers high income generation but faces trade-offs between yield and capital appreciation. The fund's performance depends heavily on market volatility for option premium income, with limited upside during strong bull markets. Key risks include concentrated tech exposure and variable dividend payments that fluctuate with market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About JPMorgan Nasdaq Equity Premium Income ETF
JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.
Read more on JEPQ →
